According to FDA prescribing information and clinical trial data, common side effects include nausea (occurring in 1544% of patients depending on dose and indication), vomiting, diarrhea, abdominal pain, and constipation
Too-high levels of some vitamins and minerals can be harmful to the body which is why the experts at IV Boost UK, London, are always monitoring patients well-being throughout their treatment programme
Above all, Medicare must start covering GLP-1 medications for weight loss via a gateway programme from July 2026, according to the Content Management System
Regular monitoring of blood sugar levels and other vital signs is necessary to guarantee optimal outcomes during treatment
Beyond muscles: the untapped potential of creatine